跳至主要内容
临床试验/IRCT20100127003210N27
IRCT20100127003210N27招募中3 期

Investigation and comparison of the effect of changing the drug regimen containing carbapenem to piperacillin/tazobactam in the treatment of hospitalized cancer patients with fever and neutropenia

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18
  • Cancer patients with fever (above 38.3 degree) and neutropenia(absolute neutrophil count below 500 per microliter)
  • Hospitalized patients

排除标准

  • Unwillingness to participate in the study
  • Patients with central vein catheter
  • Prophylactic antibiotic use before starting the study

研究者

相似试验